Evidence map›Paper›PMID 29716642›Full record

ArticleVirology journal2018

A triplex quantitative real-time PCR assay for differential detection of human adenovirus serotypes 2, 3 and 7.

Fang-Zhou Qiu, Xin-Xin Shen, Meng-Chuan Zhao, Li Zhao, Su-Xia Duan, Chen Chen, Ju-Ju Qi, Gui-Xia Li, Le Wang, Zhi-Shan Feng and 1 more

Open access · goldAbstract read
In one paragraph

Article in Virology journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Fang-Zhou QiuHebei Medical University, Shijiazhuang, 050031, Hebei, China.
Xin-Xin ShenKey Laboratory for Medical Virology, National Health and Family Planning Commission, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155 Changbai Street, Chang ping District, Beijing, 102206, China.
Meng-Chuan ZhaoChildren's Hospital of Hebei Province, Shijiazhuang, 050031, Hebei, China.
Li ZhaoHebei Medical University, Shijiazhuang, 050031, Hebei, China.
Su-Xia DuanKey Laboratory for Medical Virology, National Health and Family Planning Commission, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155 Changbai Street, Chang ping District, Beijing, 102206, China.
Chen ChenKey Laboratory for Medical Virology, National Health and Family Planning Commission, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155 Changbai Street, Chang ping District, Beijing, 102206, China.
Ju-Ju QiHebei Medical University, Shijiazhuang, 050031, Hebei, China.
Gui-Xia LiChildren's Hospital of Hebei Province, Shijiazhuang, 050031, Hebei, China.
Le WangChildren's Hospital of Hebei Province, Shijiazhuang, 050031, Hebei, China.
Zhi-Shan FengChildren's Hospital of Hebei Province, Shijiazhuang, 050031, Hebei, China. 15131129999@139.com.
Xue-Jun MaKey Laboratory for Medical Virology, National Health and Family Planning Commission, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155 Changbai Street, Chang ping District, Beijing, 102206, China. maxj@ivdc.chinacdc.cn.
National Health and Family Planning Commission · CNHospital of Hebei Province · CNHebei Medical University · CNNational Institute for Viral Disease Control and Prevention · CN

Funding

China Mega-Project for Infectious Disease 2017ZX10104001China Mega-Project for Infectious Disease 2017ZX10302301-004National key research and development plan of China 2016TFC1202700National key research and development plan of China 2016YFC1200903National key research and development plan of China 2017YFC1200503
6 · The paper itself

Abstract

backgroundHuman adenovirus (HAdV) serotypes 2, 3 and 7 are more prevalent than other serotypes and have been associated with severe pneumonia in pediatric children. Molecular typing of HAdV is not routinely performed in clinical diagnostic laboratories as it is time-consuming and labor-intensive.

methodsIn the present study, we developed a triplex quantitative real-time PCR assay (tq-PCR) in a single closed tube for differential detection and quantitative analysis of HAdV serotypes 2, 3 and 7. The sensitivity, specificity, reproducibility and clinical performance of tq-PCR were evaluated.

resultsThe analytical sensitivity of the tq-PCR was 100 copies/reaction for each of HAdV serotypes 2, 3 and 7, and no cross-reaction with other common respiratory viruses or HAdV serotypes 1,4,5,6,31,55 and 57 was observed. The coefficients of variation (CV) of intra-assay and inter-assay were between 0.6% to 3.6%. Of 138 previously-defined HAdV-positive nasopharyngeal aspirates samples tested, the detection agreement between tq-PCR and nested PCR was 96.38% (133/138).

conclusionThe proposed tq-PCR assay is a sensitive, specific and reproducible method and has the potential for clinical use in the rapid and differential detection and quantitation of HAdV serotypes 2, 3 and 7.

Indexed as

Adenoviruses, HumanAdenovirus Infections, HumanChildChild, PreschoolHumansInfantMolecular TypingMultiplex Polymerase Chain ReactionNasopharynxObserver VariationReal-Time Polymerase Chain ReactionReproducibility of ResultsRespiratory Tract InfectionsSensitivity and SpecificitySerogroupClinicalHAdVPneumoniaTriplex quantitative real-time PCR

Identifiers

PMID29716642
PMCPMC5930744
OpenAlexW2807517940

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.